# Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19

> **NCT04360759** · PHASE3 · WITHDRAWN · sponsor: **University of Cape Town**

## Conditions studied

- Covid-19
- HIV

## Interventions

- **DRUG:** Chloroquine or hydroxychloroquine

## Key facts

- **NCT ID:** NCT04360759
- **Lead sponsor:** University of Cape Town
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05-01
- **Primary completion:** 2021-05-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Equipoise for hydroxychloquine was lost
- **Last updated:** 2020-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04360759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04360759, "Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04360759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*